Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 61-68 , January 2010

Different Substrates of Non-Sustained Ventricular Tachycardia in Post-infarction Patients With and Without Left Ventricular Dilatation

  • Gianluca Di Bella, MD, PhD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • Clinical and Experimental Department of Medicine and Pharmacology, University of Messina, Messina, Italy
    • ,
  • Claudio Passino, MD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • Scuola Superiore Sant'Anna, Pisa, Italy
    • ,
  • Giovanni Donato Aquaro, MD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • ,
  • Daniele Rovai, MD, FESC

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • ,
  • Elisabetta Strata, MD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • ,
  • Francesco Arrigo, MD

      Affiliations

    • Clinical and Experimental Department of Medicine and Pharmacology, University of Messina, Messina, Italy
    • ,
  • Michele Emdin, MD, PhD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • ,
  • Massimo Lombardi, MD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • ,
  • Alessandro Pingitore, MD, PhD

      Affiliations

    • CNR, Institute of Clinical Physiology, G. Monasterio Foundation, Pisa, Italy
    • Corresponding Author InformationReprint requests: Alessandro Pingitore, MD, PhD, CNR, Clinical Physiology Institute, G. Monasterio Foundation, Via Moruzzi, 1, 56124 Pisa, Italy. Tel: 0039-050-315 2605; Fax: 0039-050-315 2166.

Received 28 November 2008 ,Revised 10 June 2009 ,Accepted 4 September 2009.

References 

  1. Moss AJ, Zareba W, Hall WJ, Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  2. Reynolds MR, Josephson ME. MADIT II (Second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003;108:1779–1783
  3. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–1482
  4. Glass L, Lerma C. Risk stratification for arrhythmic sudden cardiac death. Heart Rhythm. 2006;3:1497–1501
  5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890
  6. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;2:e1–e62
  7. Huikuri HV, Mäkikallio TH, Raatikainen MJ, Perkiömäki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation. 2003;108:110–115
  8. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, Braunwald E, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation. 2003;107:2577–2582
  9. Podrid P, Fogel R, Fuchs T. Ventricular arrhythmia in congestive heart failure. Am J Cardiol. 1992;69:82G–96G
  10. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol. 1998;32:942–947
  11. de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis. Eur J Heart Fail. 2008;10:1007–1014
  12. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007;50:1150–1157
  13. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, et al Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol. 2005;45:1064–1071
  14. Wong SP, French JK, Lydon AM, Manda SO, Gao W, Ashton NG, et al. Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction. Am J Cardiol. 2004;94:1270–1275
  15. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004;25:1940–1965
  16. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post myocardial infarction mortality. Circulation. 2006;114:32–39
  17. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006–2014
  18. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323–329
  19. Hees PS, Fleg JL, Lakatta EG, Shapiro EP. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol. 2002;90:1231–1236
  20. Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging. 2002;16:633–640
  21. Pandian NG, Skorton DJ, Collins SM, Falsetti HL, Burke ER, Kerber RE. Heterogeneity of left ventricular segmental wall thickening and excursion in 2-dimensional echocardiograms of normal human subjects. Am J Cardiol. 1983;51:1667–1673
  22. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453
  23. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after myocardial infarction: the protective effects of captopril. Circulation. 1994;89:68–75
  24. Gaudron P, Kugler I, Hu K, Bauer W, Eilles C, Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol. 2001;38:33–40
  25. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 1997;96:4065–4082
  26. Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002;8(Suppl):S319–S325
  27. Dillon SM, Allessie MA, Ursell PC, Wit AL. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res. 1988;63:182–206
  28. Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL, Cain ME. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation. 1992;86:1872–1887
  29. Richards DA, Blake GJ, Spear JF, Moore EN. Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. Circulation. 1984;69:369–381
  30. Cardinal R, Vermeulen M, Shenasa M, Roberge F, Page P, Hélie F, et al. Anisotropic conduction and functional dissociation of ischemic tissue during reentrant ventricular tachycardia in canine myocardial infarction. Circulation. 1988;77:1162–1176
  31. Bolick D, Hackel D, Reimer K, Ideker R. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation. 1986;74:1266–1279
  32. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45:1104–1108
  33. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005;112:2821–2825
  34. Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL, Cain ME. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation. 1992;86:1872–1887
  35. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, et al. Slow conduction in the infarcted human heart: ‘zigzag’ course of activation. Circulation. 1993;88:915–926
  36. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, et al. Reentry as a cause of VT in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77:589–606
  37. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, et al. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis. 1993;36:215–226
  38. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:247–346
  39. Prystowsky EN. Screening and therapy for patients with nonsustained ventricular tachycardia. Am J Cardiol. 2000;86:34K–39K
  40. Westenberg JJ, van der Geest RJ, Lamb HJ, Versteegh MI, Braun J, Doornbos J, et al. MRI to evaluate left atrial and ventricular reverse remodeling after restrictive mitral annuloplasty in dilated cardiomyopathy. Circulation. 2005;112:I437–I442
  41. Rajappan K, Bellenger NG, Anderson L, Pennell DJ. The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail. 2000;2:241–252
  42. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol. 1998;32:942–947
  43. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation. 2000;101:40–46
  44. Nakamura Y, Ebihara Y, Toyama M, Ogawa S. A predictive value of ventricular tachycardia detected by long-term electrocardiography for sudden cardiac death. Kokyu To Junkan. 1991;39:1235–1239
  45. Wichterle D, Simek J, Camm J, Malik M. Predictive characteristics of Holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. Pacing Clin Electrophysiol. 2005;28:S182–S186
  46. Anderson KP. Risk assessment for defibrillator therapy: Il Trittico. J Am Coll Cardiol. 2007;50:1158–1160

 Conflict of interest: none.

PII: S1071-9164(09)01044-6

doi: 10.1016/j.cardfail.2009.09.001

Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 61-68 , January 2010

Article Tools

* Image Usage & Resolution